Similar articles for PMID: 24975917

Year	Number of Results
1998	1
2000	1
2001	1
2002	1
2003	1
2004	6
2005	3
2006	2
2007	4
2008	4
2009	8
2010	12
2011	17
2012	21
2013	16
2014	23
2015	26
2016	32
2017	22
2018	30
2019	27
2020	18
2021	12
2022	13
2023	9
2024	0

1

Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.

Reddy K, Gaspar LE, Kavanagh BD, Chen C. Reddy K, et al. J Med Imaging Radiat Oncol. 2014 Dec;58(6):714-21. doi: 10.1111/1754-9485.12185. Epub 2014 Jun 26. J Med Imaging Radiat Oncol. 2014. PMID: 24975917 Clinical Trial.

2

Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.

Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Reddy K, et al. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):655-60. doi: 10.1016/j.ijrobp.2012.01.035. Epub 2012 Apr 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 22483738 Clinical Trial.

3

Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.

Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Chen C, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1066-74. doi: 10.1016/j.ijrobp.2010.07.021. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932651 Clinical Trial.

4

Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.

Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Carlson JA, et al. J Neurooncol. 2015 Jun;123(2):251-7. doi: 10.1007/s11060-015-1791-4. Epub 2015 Apr 29. J Neurooncol. 2015. PMID: 25920710 Clinical Trial.

5

Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.

Iuchi T, Hatano K, Kodama T, Sakaida T, Yokoi S, Kawasaki K, Hasegawa Y, Hara R. Iuchi T, et al. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):793-800. doi: 10.1016/j.ijrobp.2013.12.011. Epub 2014 Feb 1. Int J Radiat Oncol Biol Phys. 2014. PMID: 24495592 Clinical Trial.

6

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.

Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B. Jastaniyah N, et al. Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38. Radiat Oncol. 2013. PMID: 23425509 Free PMC article. Clinical Trial.

7

Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.

Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Panet-Raymond V, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):473-8. doi: 10.1016/j.ijrobp.2008.04.030. Epub 2008 Jun 12. Int J Radiat Oncol Biol Phys. 2009. PMID: 18554821

8

Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.

Shields LB, Kadner R, Vitaz TW, Spalding AC. Shields LB, et al. Radiat Oncol. 2013 Apr 25;8:101. doi: 10.1186/1748-717X-8-101. Radiat Oncol. 2013. PMID: 23618500 Free PMC article.

9

Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.

Zhong L, Chen L, Lv S, Li Q, Chen G, Luo W, Zhou P, Li G. Zhong L, et al. Radiat Oncol. 2019 Jun 13;14(1):104. doi: 10.1186/s13014-019-1305-1. Radiat Oncol. 2019. PMID: 31196126 Free PMC article. Clinical Trial.

10

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide.

Faustino AC, Viani GA, Hamamura AC. Faustino AC, et al. Clinics (Sao Paulo). 2020 Sep 11;75:e1553. doi: 10.6061/clinics/2020/e1553. eCollection 2020. Clinics (Sao Paulo). 2020. PMID: 32935821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

260 results

Results by year